Zydus Lifesciences gains on USFDA’s final approval for skin-care topical
Shares of Zydus Lifesciences traded up 1% on the morning of September 21 after the pharmaceutical company announced that it had received final approval from the United States Food and Drug Administration (USFDA) for acne treatment gel. “We have received final approval from the USFDA for clindamycin phosphate gel USP. Clindamycin is an antibiotic that …
Zydus Lifesciences gains on USFDA’s final approval for skin-care topical Read More »